If you are interested in showcasing your company’s services to senior clinical development executives from Chinese and US BioPharmas, please contact: email@example.com.
IQVIA Greater China
IQVIA has a long and prominent presence in Greater China. With offices in seven cities (Beijing, Shanghai, Guangzhou, Dalian, Chengdu, Hongkong and Taiwan) and over 2,400 employees, IQVIA has the resources, experience and site relationships necessary to help sponsors navigate the requirements, regulations and best-practices of clinical development in the region. Bridging our local expertise with our global strength, IQVIA teams in Greater China are able to tap into a robust IQVIA network and infrastructure that enables the transfer of clinical research best practices around the globe.
IQVIA is a leading global provider of information, innovative technology solutions and contract research services focused on using data and science to help healthcare clients find better solutions for their patients. Formed through the merger of IMS Health and Quintiles, IQVIA offers a broad range of solutions that harness advances in healthcare information, technology, analytics and human ingenuity to drive healthcare forward. IQVIA enables companies to rethink approaches to clinical development and commercialization, innovate with confidence as well as accelerate meaningful healthcare outcomes. IQVIA has approximately 55,000 employees in more than 100 countries, all committed to making the potential of human data science a reality. IQVIA’s approach to human data science is powered by the IQVIA CORE™, driving unique actionable insights at the intersection of big data, transformative technology and analytics with extensive domain expertise.
Precision Scientific (Beijing) CO., LTD. is a national high-tech enterprise founded in July 2015. Based on high throughput sequencing technology and multi-omics analysis, combining clinical trial design and companion diagnostic development, Precision Scientific focuses on big data mining and interpretation to build core competitiveness, and serves cancer patients，clinical specialists and pharmaceutical enterprises.
Focusing on precision medicine, Precision Scientific provides comprehensive, precise and individualized treatmentplans for cancer patients. We serve pharmaceutical companies with biomarker discovery, companion diagnostic development, trial design and clinical data analysis, precision enrollment in various forms of clinical trials. For now, we have established business relationships with hundreds of hospitals, deeply covering clinical departments of gynecology, galactophore, hepatobiliary surgery, urology surgery, gastrointestinal surgery, oncology, etc. Deeply cooperated with dozens of pharmaceutical companies.
Our company’s core team is led by Prof. Han Liang, a top international bioinformatics expert from The MD Anderson Cancer Center, and Dr. Yanxun Xu, a biostatistics expert from The Johns Hopkins University. For now, In addition to a clinical laboratory in Beijing, Precision Scientific has laboratory facilities in Suzhou, a multi-omics laboratory.
PROTECH PHARMASERVICES CORPORATION
PPC CRO, founded in 1997, is an Asia-Pacific Contract Research Organization（CRO）offering a broad range of clinical research services, including Regulatory Affairs, Medical Affairs, Medical Writing, Clinical Monitoring, Project Management, Data Management, Biostatistics and Pharmacovigilance. PPC CRO has approximately 800 employees around the world. Headquartered in Shanghai, PPC CRO operates 15 offices across China mainland including Beijing, Xuzhou, Nanjing, Guangzhou, Chengdu, Wuhan, etc. as well as overseas subsidiaries in Taiwan China, Korea, Japan, United States and etc. PPC CRO also owns 4 Phase I Clinical Pharmacology Units, 3 Bioanalytical Labs and 1 Central Lab. Throughout the past 22 years, PPC CRO has supported more than 350 customers for over 400 Phase I-IV clinical trials as well as over 800 generic drug bioequivalence studies.
At PPC CRO, more than 70% of our clients are small to midsize pharma and biotech companies. We understand a unique set of challenges faced by emerging biopharma companies, we are devoted to overcome their challenges and maximize their asset value at every stage. We provide the best fit solutions through our professionalism, which includes proven track record of therapeutic expertise, well-seasoned team, fit-for purpose process and vast network of investigator sites. We share our customers’drive to advance better therapies, their priorities are our priorities.
Fountain Medical Development Limited is a global Contract Research Organization that is able to provide Clinical Development services of the ICH standards, and is engaged in delivery of high-quality and one-stop services in Clinical Research to Pharmaceuticals and Medical Device companies from abroad and China, including Regulatory Affairs, Medical Affairs, Clinical Operations, Data Management, Biostatistics, Pharmacovigilance and third-party audits. FMD is the first CRO that can provide joint drug development services in China and simultaneously in the US, Europe, Japan, Australia and Taiwan.
PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and approximately 22,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help clients and partners bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health.
ALMAC CLINICAL SERVICES
Almac Clinical Services, part of the Almac Group, has over 30 years’ experience deploying our clinical supply chain expertise and full suite of end-to-end clinical solutions to our global clients. By listening to our customers, we understand their challenges, creating patient-centric solutions that meet evolving study and industry needs.
PSI CRO is a privately-owned, full-service clinical research organization (CRO) operating globally. PSI’s global reach supports clinical trials across multiple countries and continents and is known to be highly selective about the work that they pursue.
With an exceptionally high repeat and referral business rate combined with minimal staff turnover, PSI is committed to being the best CRO in the world as measured by its customers and its employees.
Shanghai Bestudy Medical Technology Co., Ltd. is a contract research organization (CRO) dedicated to providing professional services for the whole process of clinical trials for new drug research and development. It is committed to providing high-quality clinical trial services for sponsor by improving clinical trial rate and reducing research and development costs.In addition, it also provides registration consultation and agency of drugs and medical devices, market access consultation of foreign products into China, health economics and market access, professional training for researchers and medical and medical practitioners to improve their professional competence and professional skills.
DeltaMed is a leading specialized Contract Research Organization (CRO) dedicated to providing professional services in areas of pharmacovigilance, medical monitor and medical writing.
Pharmacovigilance services cover Safety management in full scale during the product’s whole life cycle including
-Chinese / English / Japanese case processing and submission
-Safety database management (ARISc, /Argus /BioKnow)
-Periodic safety update report (DSUR/ASR, PSUR/PBRER)
-Safety signal detection and evaluation; and risk management (RMP/REMS)
-Post-marketing Drug Intensive Monitoring (DIM) program
-Pharmacovigilance system set-up, consulting, audit and training etc.
Medical Monitoring services include
-Subject eligibility review
-Protocol deviation/ protocol violation review,
-Medical query, 24/7 medical support,
-Clinical data medical review etc.
Medical Writing services include
-Clinical development plan (CDP),
-Clinical study protocol (CSP)
-Investigator brochure (IB)
-Informed consent form (ICF),
-Clinical study report (CSR)
-Clinical overview etc.
The ECCRT is a specialised clinical research training organisation focusing on the transfer of implementable knowledge in the day-to-day activities of our participants whether being starters on the job or seasoned professionals.
Our mission is to facilitate Clinical Researchers to excel in their job for the benefit of patients. We aim to achieve this by providing clinical research professionals with competencies to develop new treatments for patients more efficient, without jeopardizing quality.
The ECCRT is in its actions supportive of the Benjamin Franklin's statement: “You tell me, and I forget. You teach me, and I remember. You involve me, and I learn.”
eStart Medical Technology
eStartMed Technology Co., Ltd. (CRO) features in early clinical trials and is proficient in FIH trials of new drug, dose escalating trials led by PK/PD, clinical evaluation of cardiac toxicity(CQT and TQT test), BE/BA studies, clinical trials of inhalants and anesthetic drugs, etc. eStartMed provides project services including phase I-Ⅳ clinical trials, project registration, project management/monitor/audit, medical affairs, data management, biostatistics, PK/PD modeling and analysis, etc, providing one station service for clinical research of sponsors home and abroad. eStartMed established Phase Ⅰclinical trial center which is operated and managed with PKUCare Luzhong Hospital (100 beds), Beijing Boren Hospital (50 beds) and Shanghai Liquan Hospital (50 beds), Beijing Dongfang Hospital (80 beds) etc. It has 280 beds, wards which are disposed according to international standard and comprehensive and sophisticated SOP. The clinical trial center strictly observes relevant regulations of NMPA and FDA, providing you international standard Phase I clinical trial service.
Flex Databases platform is a secure, unified & compliant modular software solution for clinical trials. Our platform consists of 12 modules that cover every aspect of clinical trials, from project management to pharmacovigilance. We offer both single modules and a unified solution to maintain all of your processes - you can cover all existing software needs with only one vendor. All modules developed by Flex Databases are validated and are in compliance with 21 CFR Part 11 regulations and other global regulations. Unlike traditional e-Systems developer, Flex Databases provides a combination of flexibility, fair prices and go-the-extra-mile service and support.
HANGZHOU TIGERMED CONSULTING
Hangzhou Tigermed Consulting Co., Ltd（stock symbol: 300347） is a leading Contract Research Organization (CRO) in China dedicated to provide professional full clinical trial services. Tigermed has been committed to accelerating medical product development with costs efficiency and quality.
Headquartered in Hangzhou, Tigermed operates 97 offices in China, including one in Hong Kong China and one in Taiwan China. And 9 overseas offices in Korea,Japan and Romania etc. with over 4500 full time staffs. Tigermed has serviced more than 600 local and global clients in the conduct of over 1500 clinical trials. Tigermed is recognized as “The Innovative CRO” in China，owning to our involvement of over 100 innovative drugs.
Contact: www.tigermed.net Email:firstname.lastname@example.org
Happy Life Technology （HLT） is the leading provider of innovated healthcare solutions. In healthcare industry, HLT is committed to apply leading big data science and artificial intelligence technology to the management of product full-life cycle services, and provide healthcare enterprises with innovated solutions to help enterprises be faster, more excellent and more precise in new products research and development, new product launch and post launch marketing.
For more information, visit www.hltpharma.com.
Shanghai Jsure Health Technology Co., Ltd. was established in 2008. Jsure Health adheres to the "patient-centered" philosophy, focuses on China's clinical research career, and provides integrated clinical research and innovative digital patient management solutions for pharmaceutical enterprises. Jsure has established close relationships with 200+ sites and 20,000+ physicians and had experience in more than 350+ clinical research projects across 40+ disease areas. Jsure helps 40 new drugs accelerate the approval of the market, and brings hope to life for 80,000+ patients. Jsure Health listed on the new OTC market in 2015.
Jsure Health's solutions include patient recruitment services（信募™）, China 's ePRO complete solutions（ePData™）, and ePRO-driven disease management solutions with digital supporting for pharmaceutical enterprises, physicians, and patients（ePConnect™）. Jsure Health helps pharmaceutical enterprises accelerate the pace of clinical research and the approval of the market and promotes the development of the medical and health industry.
Learn more, please visit our web site at: www.jsure.com.
KoNECT is a non-profit government organization affiliated with the Korean Ministry of Health and Welfare. We support all clinical trial sponsors who are interested in working with Korea’s clinical trial sites, investigators and partners, by providing various information and services through KoNECT Collaboration Center. (Please visit us at http://kcc.konect.or.kr)
Medidata is leading the digital transformation of life sciences, with the world's most-used platform for clinical development, commercial, and real-world data. Powered by artificial intelligence and delivered by the #1 ranked industry experts, Medidata helps pharmaceutical, biotech, medical device companies, and academic researchers accelerate value, minimize risk and optimize outcomes. Medidata and its companies, Acorn AI and SHYFT, serve more than 1,200 customers and partners worldwide and empower more than 150,000 certified users every day to create hope for millions of patients. Discover the future of life sciences: www.medidata.com.
PRA HEALTH SCIENCES
PRA has been delivering innovative drug development solutions in China for nearly a decade and continue that work through our locations in Beijing, Shanghái and Dalian.
We strive to move drug discovery forward side-by-side with our clients, helping them to develop live-saving and life-improving drugs. We provide comprehensive clinical development and data services across all phases with our unique blend of expertise and technology. From full-service clinical development to our pioneering Embedded Solutions™ model, PRA offers a broad spectrum of solutions that meet the demands of a diverse marketplace.
As a top five CRO, we have worked on 100+ marketed drugs across several therapeutic areas and conducted the pivotal or supportive trials that led to FDA and/or international regulatory approval of more than 75 such drugs.
PRA provides the local and global presence you need, with 15,500+ employees covering over 85 countries, combined with an in-depth knowledge of local regulations, standards of care, and the cultural customs our clients expect.
Our mission in China is to build the most comprehensive and flexible offering to support our clients with global trials, embedded teams, in-house biometrics, and local trials in China.
Proswell Medical Company
Proswell Medical Company, established in 2004, provides a wide range of world-class services for clinical trial and pharmaceutical development for domestic and oversea customers . Proswell takes on the responsibility for creating an international brand by local clinical Contracted Research Organization (CRO) and promoting the development of China CRO Industry. Proswell successfully passed ISO 9001:2008 Quality Management System Certification in January 2010 and became the first local certified CRO in China. This achieve- ment represents Proswell’s sincerity, dedication, professionalism and commitment to its partners and customers to provide clinical trial service with supreme-quality and balanced-efficiency!
Shanghai Yongzheng Medical Science and Techology
Shanghai Yongzheng Medical Science and Technology Co., Ltd. is one of the earliest clinical contract research organizations (CRO) with 15 years of steady and sound running state, focusing on providing full clinical services for pharmaceutical products research and development. Yongzheng concentrates on developing its core business such as trial management, data management & biostatistics and pharmacovigilance. Simultaneously, Yongzheng also develops other business which related to the core business, such as regulatory affairs, medical affairs and SMO. We focus on project management and consolidation of service foundation, which forms Yongzheng’s service advantage.
Shanghai Sheng Sheng Logistics Co., Ltd. is a Outstanding, professional medical and biological cold chain logistics company. Since its establishment in 2009, it has been focused on providing safe, professional and efficient cold chain logistics solutions for customers in the fields of life science, biotechnology and drug R&D. We are committed to help our customers to success in their area in China and all over the world.
Signant Health puts patients at the center of clinical research, by simplifying their journey through clinical trials. Our focus on the patient experience, deep therapeutic area expertise and global operational scale enable hundreds of sponsors and CROs bring life-changing therapies to our families and communities around the world.
Syneos Health™ (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Learn more about how we are shortening the distance from lab to life® at syneoshealth.com.